Cardioneuroablation for Neurocardiogenic Syncope

Exclusion Criteria

• •Subject has signs and symptoms of an active infection (i.e. fever, elevated white blood cell count, etc.) which has not been treated and/or has not demonstrated improvement in white blood cell count and resolution of fever
• •Subject is pregnant or planning to become pregnant within the study protocol follow-up
• •Subject is enrolled or planning to participate in a concurrent drug and/or device study during the course of this study that would confound study results as determined by the study physician
• •Subject is unwillingly to comply with the randomization procedure
• •Subject has had no syncopal episodes in last six months while on medical therapy
• •Subject has one of the following conditions that is the documented source of syncope: sick sinus syndrome, sinus node or atrioventricular conduction deficiencies, ventricular tachyarrhythmias, pulmonary hypertension, hypertrophic cardiomyopathy, history of transient ischemic attack, seizure disorders, subclavian steal syndrome, or drug-induced syncope
• •Subjects with a myocardial infarction within last six months
• •Subjects with severe heart failure (NYHA class III or IV), previous heart surgery, structural heart disease, or an infiltrative cardiac disease
• •Subject is contraindicated for left-atrial ablation, as determined by enrolling physician